These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 31915140

  • 1. HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia.
    Huot JR, Novinger LJ, Pin F, Bonetto A.
    Dis Model Mech; 2020 Jan 24; 13(1):. PubMed ID: 31915140
    [Abstract] [Full Text] [Related]

  • 2. MC38 Tumors Induce Musculoskeletal Defects in Colorectal Cancer.
    Huot JR, Pin F, Essex AL, Bonetto A.
    Int J Mol Sci; 2021 Feb 02; 22(3):. PubMed ID: 33540821
    [Abstract] [Full Text] [Related]

  • 3. ACVR2B antagonism as a countermeasure to multi-organ perturbations in metastatic colorectal cancer cachexia.
    Huot JR, Pin F, Narasimhan A, Novinger LJ, Keith AS, Zimmers TA, Willis MS, Bonetto A.
    J Cachexia Sarcopenia Muscle; 2020 Dec 02; 11(6):1779-1798. PubMed ID: 33200567
    [Abstract] [Full Text] [Related]

  • 4. Formation of colorectal liver metastases induces musculoskeletal and metabolic abnormalities consistent with exacerbated cachexia.
    Huot JR, Novinger LJ, Pin F, Narasimhan A, Zimmers TA, O'Connell TM, Bonetto A.
    JCI Insight; 2020 May 07; 5(9):. PubMed ID: 32298240
    [Abstract] [Full Text] [Related]

  • 5. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.
    Bonetto A, Aydogdu T, Jin X, Zhang Z, Zhan R, Puzis L, Koniaris LG, Zimmers TA.
    Am J Physiol Endocrinol Metab; 2012 Aug 01; 303(3):E410-21. PubMed ID: 22669242
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia.
    Pin F, Barreto R, Kitase Y, Mitra S, Erne CE, Novinger LJ, Zimmers TA, Couch ME, Bonewald LF, Bonetto A.
    J Cachexia Sarcopenia Muscle; 2018 Aug 01; 9(4):685-700. PubMed ID: 30009406
    [Abstract] [Full Text] [Related]

  • 9. Group I Paks support muscle regeneration and counteract cancer-associated muscle atrophy.
    Cerquone Perpetuini A, Re Cecconi AD, Chiappa M, Martinelli GB, Fuoco C, Desiderio G, Castagnoli L, Gargioli C, Piccirillo R, Cesareni G.
    J Cachexia Sarcopenia Muscle; 2018 Aug 01; 9(4):727-746. PubMed ID: 29781585
    [Abstract] [Full Text] [Related]

  • 10. Imperatorin alleviates cancer cachexia and prevents muscle wasting via directly inhibiting STAT3.
    Chen L, Xu W, Yang Q, Zhang H, Wan L, Xin B, Zhang J, Guo C.
    Pharmacol Res; 2020 Aug 01; 158():104871. PubMed ID: 32413482
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of heat shock protein (HSP) 90 reverses signal transducer and activator of transcription (STAT) 3-mediated muscle wasting in cancer cachexia mice.
    Niu M, Song S, Su Z, Wei L, Li L, Pu W, Zhao C, Ding Y, Wang J, Cao W, Gao Q, Wang H.
    Br J Pharmacol; 2021 Nov 01; 178(22):4485-4500. PubMed ID: 34265073
    [Abstract] [Full Text] [Related]

  • 14. Ursolic acid alleviates cancer cachexia by inhibiting STAT3 signaling pathways in C2C12 myotube and CT26 tumor-bearing mouse model.
    Chen L, Chen Y, Wang M, Lai L, Zheng L, Lu H.
    Eur J Pharmacol; 2024 Apr 15; 969():176429. PubMed ID: 38423241
    [Abstract] [Full Text] [Related]

  • 15. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway.
    Ying L, Yao Y, Lv H, Lu G, Zhang Q, Yang Y, Zhou J.
    Am J Physiol Cell Physiol; 2022 May 01; 322(5):C814-C824. PubMed ID: 35319902
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia.
    Bonetto A, Aydogdu T, Kunzevitzky N, Guttridge DC, Khuri S, Koniaris LG, Zimmers TA.
    PLoS One; 2011 May 01; 6(7):e22538. PubMed ID: 21799891
    [Abstract] [Full Text] [Related]

  • 18. Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK.
    White JP, Puppa MJ, Gao S, Sato S, Welle SL, Carson JA.
    Am J Physiol Endocrinol Metab; 2013 May 15; 304(10):E1042-52. PubMed ID: 23531613
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.